PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA: BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS
| Autor: | Ionescu, A., Agnarson, M.A., Kambili, C., Kfoury, J., Steven, W., Singh, V., Williams, A., Thomas, A. |
|---|---|
| Zdroj: | In Value in Health October 2018 21 Supplement 3:S411-S411 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect